Integrins and NAFLD-associated liver diseases: clinical associations, pathophysiological mechanisms and pharmacological implications
2024

Integrins and Liver Diseases

publication Evidence: moderate

Author Information

Author(s): Ni Yangyue, Huang Mengwen, Chen Shiyang, Wang Shihui, Chen Jianfeng

Primary Institution: University of Chinese Academy of Sciences

Hypothesis

Integrins play a crucial role in the pathophysiology of NAFLD and its progression to more severe liver diseases.

Conclusion

Integrins are involved in the onset and progression of NAFLD and may serve as therapeutic targets for treatment.

Supporting Evidence

  • NAFLD is a leading cause of chronic liver disease globally.
  • Integrins regulate various aspects of NAFLD onset and progression.
  • Integrins are involved in immune cell infiltration and liver inflammation.
  • Targeting integrins may provide new therapeutic options for NAFLD.

Takeaway

Integrins are like tiny glue that helps cells stick together in the liver, and they can help us understand and treat liver diseases better.

Methodology

This review summarizes the role of integrins in NAFLD and discusses current findings on drugs targeting integrins.

Limitations

The review is based on existing literature and may not include all recent studies.

Digital Object Identifier (DOI)

10.3724/abbs.2024149

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication